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During the course of a psychophysical study of ﬁbromyalgia syndrome (FMS), one of the subjects with a long history of headache
and facial pain displayed an extraordinarily severe thermal allodynia. Her stimulus-response function for ratings of cutaneous
heat pain revealed a sensitivity clearly beyond that of normal controls and most FMS subjects. Specially designed psychophysical
methods showed that heat sensitivity sometimes increased dramatically within a series of stimuli. Prior exposure to moderate heat
pain served as a trigger for allodynic ratings of series of normally neutral thermal stimulation. These observations document a case
of breakthrough pain sensitivity with implications for mechanisms of FMS pain.
1.Introduction
Fibromyalgia syndrome (FMS) is characterized by widesp-
read hyperalgesia and allodynia for mechanical and thermal
s t i m u l io fd e e pa n ds u p e r ﬁ c i a lt i s s u e s[ 1]. The magnitude,
distribution, and frequency of the clinical pain and the
responses to experimental stimuli vary widely [2, 3] suggest-
ing to some: (1) that FMS represents the upper portion of
the normal distribution of pain sensitivity [4], (2) that indi-
viduals with FMS are predisposed by their genetic makeup
and psychological history to exhibit exaggerated pain eﬀect
(catastrophize) [4, 5] and therefore (3) that chronic FMS
represents a psychological pain state. According to these
suppositions, the widespread hypersensitivity characteristic
of FMS would be associated with excessive activation of
cortical levels involved in aﬀective interpretation of pain
[6, 7], without abnormal processing within pain pathways
extending from the periphery to the initial stages of cortical
somatosensory processing.
The FMS patient presented here drew our attention
because of the clinical severity of her disease and an
abnormal sensitivity to cutaneous thermal stimulation. This
prompted us to thoroughly evaluate her pain sensitivity
with psychophysical methods that can reveal abnormal
processing within primary pain pathways. This patient’s high
sensitivity to thermal stimulation reveals pathophysiogical
pain processing. The studies were conducted with informed
consent and approval by the IRB of the University of Florida.
2.ClinicalDescription
The patient initially presented with complaint of “hurting all
over and being extremely fatigued”. She met the ACR criteria
for FMS with typical symptoms, as well as physical ﬁndings
[8]. These symptoms included severe headaches, nonrestora-
tive sleep without other ﬁndings of a primary sleep disorder,
sensations of weakness in her upper and lower extremities,
profound fatigue, hypotensive/fainting episodes, Reynaud’s
phenomenon with cold and clammy feet and hands, and
TMJ disorder. Her past history was signiﬁcant for migraine
headache disorder with aura since childhood. She denied any
previoustraumaexceptarighthandfracturein1998without
residuals. There was no history of sexual/verbal/physical
abuse, mental health problems, or drug abuse. She noted
slow but steadily increasing, generalized pain since her
adolescence and reported that her headaches were largely2 Pain Research and Treatment
uncontrolled during her childhood. Better control of pain
was achieved with a variety of medications in her later years;
however, she noted extreme generalized pain in 2001 as
she was trying to come oﬀ medications. She has been on
medroxyprogesterone (Depo Provera) for birth control.
Generalized pain and associated symptoms continue,
despite a variety of treatments. In general, they have slowly
worsened, and she has experienced increasing problems
staying functional. She has not developed signiﬁcant mental
health comorbidities. She underwent neuropsychological
evaluation twice, and there was no diagnosis of somatization
disorder, depression, or anxiety disorder. She was found to
have a learning disability (reading disorder).
There have been no signs of connective tissue disease:
that is, synovitis, joint eﬀusions, or deformities. Her joints
reveal some hypermobility, which has always been present.
She has developed some osteoarthritis of the knees, lower
back and shoulders. She has FMS tender points ranging
from 13/18–18/18, irritation to the occipital nerves, and
ongoing myofascial pain (MFP) trigger point areas. Of note,
she has developed more sympathetic nervous system signs,
with diﬀuse skin mottling and cold and clammy hands and
feet. Her vital signs, including blood pressure, respiratory
rate, and weight have all remained stable and normal.
However, her heart rate is elevated (102–120) and felt to be
secondary to her medications, particularly cyclobenzaprine
(Flexeril). Her laboratory studies were and have remained
normal, including CBC, chemistry proﬁle, sedimentation
rate, antinuclear antibody, rheumatoid factor, highly sensi-
tive C-reactive proﬁle, Vitamin B12, and thyroid studies.
Treatments have been multidisciplinary, including phar-
macological and nonpharmacological procedures. Her cur-
rent regimen has kept her functioning with regular activ-
ities of daily living (ADLs). She is taking: topiramate
(Topamax) 50mg bid, cyclobenzaprine (Flexeril) 20mg
qhs, hydrocodone/acetaminophen 10/500 1–2 q6–8 hours,
zolpidem (Ambien CR) 12.5qhs, sumatriptan/naprosyn
(Treximet)1p.o. PRN, sumatriptan injectable (Imitrex)
PRN, promethazine (Phenergan) 25mg 1q8 hours PRN
nausea/vomiting, medroxyprogesterone (Depo Provera),
and supplements, including magnesium 750mg qd and
CoenzymeQ10 150mg bid.
Over the years, she has tried other medications with
varying results and side eﬀects: NSAIDs with signiﬁcant GI
upset, occasional naprosyn, gabapentin (Neurontin) with
numbness and fogginess, pregabalin (Lyrica) with severe
mental fogginess, duloxetine (Cymbalta) with headaches
and nausea, citalopram (Celexa) with weird feelings, glu-
cosamine and chondroitin no help, seroquetiapine (Sero-
quel) with severe headaches and could not think, mir-
tazepine (Remeron) no help, zolpidem (Ambien) lost its
eﬀectiveness, zolmitriptan (Zomig) with dizziness, riza-
triptan (Maxalt) lost eﬀectiveness, various beta blockers,
for example, metoprolol, atenolol lost its eﬀectiveness, all
Cox 2 inhibitors caused side eﬀects and were ineﬀective,
meperidine (Demerol) with nausea, ﬂuoxetine (Prozac) no
help, and paroxetine (Paxil) lost its eﬀectiveness over time.
Nonpharmacological treatments included cognitive be-
havioral therapy and pain management counseling (helped
withpaincoping),physicaltherapy(helpedwithintermittent
exacerbations of the MFP), massage therapy (which made
her condition more painful), trigger point injections and
occipital nerve blocks (helped when she had typical occipital
neuralgia ﬁndings), and dietary adjustments becoming a
lacto vegetarian.
Distribution of FMS Pain. At the beginning of each session
(before experimental procedures were undertaken), the
patient was asked to localize currently active pain sites on
a diagram and rank the locations according to pain severity
(Figures 1 and 2). In all cases pain was present in at least
3quadrants of the body.
3. Study 1. Stimulus-Response Relationship
(SingleStimuli)
3.1.Methods. Inourinitialattempttoevaluatethecutaneous
pain sensitivity of the FMS patient, a solenoid-powered
mechanism brought a Peltier-based thermode (23 × 23mm)
into and out of light skin contact. The hypothenar eminence
of the left hand was contacted for 3sec, with an inter-
stimulus interval (ISI) of 30sec. The temperature was set to
29
◦C at the beginning of the test. This is approximately 15
◦C
belowpainthresholdofhealthyindividualsforthisthermode
size and stimulus duration. The temperature increased in
1◦C increments for each contact until a pain rating of 50%
wasreached.Thesubjectratedpainintensitybyadjustingthe
slider of an electronic visual analog scale (eVAS) within 5sec
after the end of each pulse. The left and right endpoints of
the slider were deﬁned as “no pain” and “intolerably intense
pain”, respectively. The position of the slider (and therefore
pain intensity) was recorded as a numerical value from 0 to
100%.
3.2. Results. The stimulus-response (S-R) curve for the FMS
patient (Figure 3) was far to the left of those of all other
FMS patients we have tested. Thermode temperatures as low
as 33.7
◦C were rated as moderately painful (25% on the
eVAS) for the extremely sensitive FMS patient, compared
to 49.2
◦Cf o rF M Sg r o u pa n d5 2 .2
◦C for the control group
(group means). This standard psychophysical procedure
demonstrated an extraordinary level of sensitization to
thermal stimulation for the severe FMS patient of this study.
4. Study 2. Temporal Summation (Windup)
of Thermal Pain
4.1. Methods. Repetitive series of thermal cutaneous stimuli
can provide information on mechanisms for sensitized states
of chronic pain patients. For example, temporal summa-
tion (windup) of thermal pain by stimuli that activate C
nociceptors has been shown to result from NMDA-receptor-
dependent central sensitization within pain pathways from
the spinal cord to the primary somatosensory cortex [9–11].
Accordingly, the thenar eminence of the left hand (glabrous
skin) of the FMS patient, was contacted repetitively with
the solenoid driven thermode (23×23mm) set to 41
◦C.Pain Research and Treatment 3
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Figure 1: Spatial pattern of spontaneous pain of the FMS patient prior to psychophysical testing.
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Figure 2: Spontaneous pain in the upper and lower body was rated
withanelectronicvisualanalogscale(eVAS)from0(nopain)to100
(intolerably intense pain). The unpleasantness of the most severe
pain overall was rated on a scale ranging from 0 (“not unpleasant”)
to 100 (“the most unpleasant imaginable”).
Thermal pulse durations (PDs) of 0.7sec were delivered at
an interstimulus interval (ISI) of 2.5sec.
4.2. Results. Normal subjects and typical FMS patients
temporally summate when presented with a PD of 0.7sec
andanISIof2.5second,but49
◦Corhighert emperatur esar e
required. At these temperatures, ratings begin near zero and
reach a plateau at moderate to high pain intensity levels after
10 to 15stimuli [9, 12]. In contrast, ratings of pain intensity
induced by the ﬁrst stimulus to our FMS patient exceeded
50% and rapidly escalated to a plateau of approximately 85%
(Figure 4).
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Figure 3: Series of thermal contact stimuli (pulse duration: 3
sec; ISI: 30 sec) were administered to the hypothenar eminence
of the left hand. Red traces: S-R curves of the extremely sensitive
FMS subject, acquired on two diﬀerent days. For comparison,
the mean curve-ﬁtted (TableCurve2D by Systat, Chicago, IL), S-R
curves from 12 typical FMS subjects (orange trace), and 12 healthy
controls (blue trace) are presented. The borders of the colored
bands represented the range of each group‘s data (from minimum
to maximum). The thermal pain sensitivity of the severely sensitive
FMS subject was far outside the range of the FMS group.
5. Study 3. RapidTransition to an Extreme
Level of Sensitization
5.1.Methods. RatingsbytheFMSpatientoftheﬁrststimulus
in the windup series revealed a high sensitivity to short
pulses of heat stimulation that normally evoke pain only
after repetition at a rate that progressively activates NMDA
receptors (≤3sec ISI) [9] .I no r d e rt of u r t h e re v a l u a t e
temporal summation by this sensitized patient, we utilized a4 Pain Research and Treatment
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Figure4:eVASpainratingsofrepetitivethermalstimulation(41
◦C,
PD 0.7 sec, ISI 2.5 sec),on the right (open squares) and then the left
(solid diamonds) thenar eminence of the FMS patient.
new paradigm (designed by A.P.M.) that permits variation
of a stimulus parameter within a series of stimuli. The
ﬁxed parameters were a PD of 0.7sec and a temperature
that elicited a low level of pain early in a series for the
FMS patient (36
◦C). The remaining parameter, ISI, was
adjusted by software as a function of the patient’s eVAS
rating. When windup occurred and pain intensity reached
a predetermined set point (40%), ISI was increased from
an initial value of 2.5sec to maintain the ratings near
the setpoint (pain intensity clamping). With this protocol,
increasing ISIs indicate sensitization (prolonged temporal
summation).
5.2. Results. During the session shown in Figure 5 the ther-
mode was at a temperature (36
◦C) that is barely perceived
as warm and does not produce temporal summation in
healthy individuals. For the FMS patient ISIs of 5 sec or less
maintained pain levels near the 40% setpoint for the ﬁrst
13pulses of stimulation, and then substantial increases in
ISI (to 24sec) were required to maintain pain ratings near
40%. Thus, the FMS patient sensitized during stimulation
at ISIs far beyond the longest that will maintain temporal
summation of pain for a normal subject (approximately
6sec) tested at a higher temperature [9]. Maintenance of
temporal summation by infrequent stimulation has been
demonstrated previously for FMS subjects [13], but it was
extreme for the patient described here, considering the low
temperature and long ISIs.
6.Study4.SensitizationInducedby
PainfulStimulation
6.1. Methods. Pain intensity clamping indicated that the
extraordinary thermal sensitivity of this patient increased
further after receipt of painful stimulation. To determine
whether pain is a determining factor for the allodynic states
ofthispatient,threeseriesofrepetitivepulses(PD0.7sec,ISI
2.5sec) were presented. The ﬁrst series involved stimulation
of the right thenar eminence with the thermode at skin
temperature (32.5
◦C, measured with a Dermatemp infrared
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Figure 5: Pulse duration (0.7sec) and thermode temperature
(36
◦C) remained unchanged throughout a series of 35 stimuli. Pain
intensity was clamped to 40% by adjusting ISI.
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Figure 6: Identical pulse series (PD 0.7 sec, ISI 2.5 sec, thermode
temperature same as measured skin temperature, i.e., 32.5
◦C) were
administered to the right thenar eminence before (baseline) and
after (conditioned) a series of painful stimulation. The intervening
series of painful stimuli induced sensitization.
temperature scanner model DT-1001; Exergen Corp., Water-
town, MA, USA). Ratings of sensation intensity remained
near pain threshold (<10%) across the entire series. Second,
a painful series of stimuli was presented for 8minutes,
with clamping of pain intensity at 40% by varying probe
temperature.
6.2. Results. Following the painful second series, a third
series of pulses was delivered at skin temperature. Pain
intensity progressed from below 10% to approximately 25%
(Figure 6). This suggests that the intervening (second) series
of painful stimuli triggered (or enhanced) an allodynic state
during the third series.
7. Study 5. Thermal Stimulation
without a MechanicalComponent
7.1. Methods. In all tests described thus far, the thermal
stimulus was accompanied by mechanical contact of the
thermode with the skin, so that discrimination betweenPain Research and Treatment 5
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Figure 7: The FMS patient received 2 pain intensity clamping series (ﬁrst series: dotted line; second series: solid line). The thermode
remained in contact with the skin throughout the session, and the temperature was automatically adjusted to maintain an eVAS rating
of 35%. The experiment was conducted with (b) and without (a) an intervening series of more painful stimuli (conditioning stimulus).
The intervening conditioning stimuli sensitized the patient, as evidenced by a progressively decreasing temperature during the second 35%
clamping test.
mechanical and thermal allodynia could not be made.
Therefore, pain sensitivity was probed with a purely thermal
stimulus. First, a two-minute period of continuous thermal
stimulation (dotted lines in Figure 7) was administered with
the thermode temperature automatically adjusted up and
down in 1.5sec intervals to maintain eVAS ratings near
a 35% setpoint. The size of each adjustment step was a
function of the diﬀerence of the pain intensity rating from
the setpoint (proportional control) and the direction and
magnitude of the trend (derivative control). This method
of intensity adjustment permits long duration stimulation
while maintaining sensation intensity at a desired and
tolerable level as sensitization or adaptation progresses. The
test was repeated 35 minutes later (solid line in Figure 7)
withorwithoutaninterveningseriesofmorepainfulstimuli.
During the intervening series of thermal pulses (PD 3 sec, ISI
30sec), the temperature increased in 0.5
◦Cs t e p sf r o m4 3t o
49
◦C.
7.2. Results. During the repeat tests of 35% clamping (solid
lines in Figure 7), the FMS subject exhibited progressive
sensitization (a decrease in temperature to maintain ratings
of 35%) only after the intervening series of painful stimuli
Figure 7(b). Toward the end of the test after the intervening
series, no more than 33
◦C was required to maintain 35%
pain intensity. Thus, mild thermal pain (the ﬁrst series of
35% clamping) did not aﬀect ratings during a second series
of 35% clamping Figure 7(a), but strong intervening pain
substantially sensitized the patient, as revealed during a
second series of 35% clamping. There was no contribution
of mechanical stimulation to this eﬀect.
8. Discussion
An individual with a long history of headache and TMJ
pain presented with the diagnostic features of FMS. She
is remarkably free of mental health comorbidities (e.g.,
depression), and her FMS pain has not been alleviated
by a variety of medications, including antidepressants. An
etiological factor for establishment and maintenance of her
generalized FMS pain and hypersensitivity may be chronic
stressassociatedwithfocalheadacheandfacialpainformuch
of her life. Her clinical proﬁle included autonomic signs
suggestive of chronic stress. Psychophysical studies showed
that exposure to nociceptive stimulation, which triggers an
acute stress reaction [14, 15], switches the pain processing
of this FMS patient into a diﬀerent mode of operation.
Extreme temporal summation of cutaneous thermal pain
was observed after receipt of a stimulus that elicits a
moderate to high intensity of pain.
The psychophysical tests reported here demonstrate that
the allodynia of this patient cannot be characterized simply
as a generalized exaggeration of normally encoded pain.
Abnormally high ratings of sensation intensity were dictated
by the intensity and timing of present and preceding stim-
ulations when the patient was blind to changes in stimulus6 Pain Research and Treatment
parameters within and between tests. Moderate to high levels
of pain produced a dramatic and long-lasting sensitization
for subsequent thermal stimulation. These relationships
between stimulus parameters and pain intensity reﬂect
abnormal temporal and intensive processing within pain
pathways rather than (or in addition to) a heightened impact
of nociceptive input to higher cortical centers for aﬀective
interpretation. Investigation of mechanisms of chronic pain
can beneﬁt from a thorough psychophysical examination of
patients with pronounced symptoms.
Acknowledgments
Funding: NIH NINDS 1K23NS43435 and NIH NIDCR U24
DE016509.
References
[1] P. J. Mease, D. J. Clauw, L. M. Arnold, et al., “Fibromyalgia
syndrome,” Journal of Rheumatology, vol. 32, no. 11, pp. 2270–
2277, 2005.
[2] D. C. Turk, A. Okifuji, J. D. Sinclair, and T. W. Starz, “Pain,
disability, and physical functioning in subgroups of patients
with ﬁbromyalgia,” Journal of Rheumatology, vol. 23, no. 7, pp.
1255–1262, 1996.
[3] T. Giesecke, D. A. Williams, R. E. Harris, et al., “Subgrouping
of ﬁbromyalgia patients on the basis of pressure-pain thresh-
olds and psychological factors,” Arthritis and Rheumatism, vol.
48, no. 10, pp. 2916–2922, 2003.
[4] E. Mayer, “Functional pain disorders: time for a paradigm
shift?” in Functional Pain Syndromes: Presentation and Patho-
physiology, pp. 531–565, IASP Press, Seattle, Wash, USA, 2009.
[ 5 ]F .R .J .N a l i b o ﬀ, “Anxiety in functional pain disorders,” in
FunctionalPainDisorders:PresentationandPathophysiology,E.
Mayer,Ed.,pp.185–214,IASPPress,Seattle,Wash,USA,2009.
[ 6 ]R .H .G r a c e l y ,M .E .G e i s s e r ,T .G i e s e c k e ,e ta l . ,“ P a i n
catastrophizing and neural responses to pain among persons
with ﬁbromyalgia,” Brain, vol. 127, part 4, pp. 835–843, 2004.
[ 7 ]I .A .S t r i g o ,A .N .S i m m o n s ,S .C .M a t t h e w s ,A .D .C r a i g ,
and M. P. Paulus, “Association of major depressive disorder
withalteredfunctionalbrainresponseduringanticipationand
processingofheatpain,”ArchivesofGeneralPsychiatry,vol.65,
no. 11, pp. 1275–1284, 2008.
[8] S. E. Geel, “The ﬁbromyalgia syndrome: musculoskeletal
pathophysiology,” Seminars in Arthritis and Rheumatism, vol.
23, no. 5, pp. 347–353, 1994.
[9] C. J. Vierck Jr., R. L. Cannon, G. Fry, W. Maixner, and B. L.
Whitsel, “Characteristics of temporal summation of second
pain sensations elicited by brief contact of glabrous skin by a
preheated thermode,” Journal of Neurophysiology, vol. 78, no.
2, pp. 992–1002, 1997.
[10] M. Tommerdahl, K. A. Delemos, O. V. Favorov, C. B. Metz, C.
J. Vierck Jr., and B. L. Whitsel, “Response of anterior parietal
cortex to diﬀerent modes of same-site skin stimulation,”
JournalofNeurophysiology,vol.80,no.6,pp.3272–3283,1998.
[11] A. D. Craig and D. Andrew, “Responses of spinothalamic
lamina I neurons to repeated brief contact heat stimulation in
the cat,” Journal of Neurophysiology, vol. 87, no. 4, pp. 1902–
1914, 2002.
[12] D. D. Price, R. Staud, M. E. Robinson, A. P. Mauderli, R.
Cannon, and C. J. Vierck, “Enhanced temporal summation
of second pain and its central modulation in ﬁbromyalgia
patients,” Pain, vol. 99, no. 1-2, pp. 49–59, 2002.
[13] R. Staud, D. D. Price, M. E. Robinson, A. P. Mauderli, and
C. J. Vierck, “Maintenance of windup of second pain requires
less frequent stimulation in ﬁbromyalgia patients compared to
normal controls,” Pain, vol. 110, no. 3, pp. 689–696, 2004.
[14] C. J. Vierck Jr., “Mechanisms underlying development of
spatially distributed chronic pain (ﬁbromyalgia),” Pain, vol.
124, no. 3, pp. 242–263, 2006.
[15] C. J. Vierck, M. Green, and R. P. Yezierski, “Pain as a stressor:
eﬀects of prior nociceptive stimulation on escape responding
of rats to thermal stimulation,” European Journal of Pain, vol.
14, no. 1, pp. 11–16, 2010.